Internal: Archive

New worries for Switzerland’s troubled national exhibition

This content was published on Apr 5, 2001 In 1999, the government promised it would provide the additional funds if exhibition organisers raised an identical amount of money through sponsorship from small and medium-sized Swiss companies. Exhibition organisers have so far only been able to attract SFr2 million from the companies. According to Expo.02’s finance chief, Walter Häusermann, small and medium-sized companies “seem…

Prizes awarded for future scientific projects

This content was published on Apr 5, 2001 The first project, led by two scientists from Lausanne, is looking at ways of grafting new and perfectly functioning heart cells onto the hearts of patients suffering from cardiac failure. Dr Freddy Ratke, a biologist at the Ludwig Institute for Cancer Research in Lausanne and Dr Thierry Pedrazzini, a biochemist at the University of Lausanne…

Row grows over Swiss handling of foot-and-mouth disease

This content was published on Apr 5, 2001 Despite growing fears among farmers that the disease may infiltrate Swiss borders, the government has refused to launch a mass vaccination programme for livestock. “It’s just not practical to vaccinate en masse,” said Christian Gorot, head of animal diseases at the Federal Veterinary Office. “We would need to vaccinate at least 3.6 million animals and…

Cheaper alcohol undermines efforts to combat abuse

This content was published on Apr 5, 2001 In the two years since the IAP’s prevention campaign was launched, the number of people abusing alcohol has declined by three per cent, with most of the improvement being accounted for by women. However, the figures mask worrying trends in drinking patterns, especially among men and young people. The executive director of the IAP, Richard…

Novartis wins EU approval for diabetes treatment

This content was published on Apr 5, 2001 Starlix is the first in a new class of type 2 diabetes treatments, and is already on sale in the United States, Switzerland and Brazil. Novartis said on Thursday that it had been approved in the EU for use in combination with a second drug, metformin. Together, they help to prevent the body’s insulin levels…

Crossair forecasts return to profit

This content was published on Apr 5, 2001 “Crossair has made a good start to 2001,” the airline said in a statement released at its annual earnings news conference on Thursday. It added: “The financial result to date is already above budget, which is based on a profitable year.” Between January and March the airline carried 690,265 passengers, an increase of nine per…

Say it with flowers from Africa

This content was published on Apr 5, 2001 The Basel-based organisation is lending its fair trade label to roses grown on farms in Kenya and Zimbabwe. A premium imposed on the Swiss retail price will be ploughed back into the communities to improve the lives of the people there. The 12 farms involved in the project have signed contracts with the Foundation promising…

Swiss lead the world in train travel

This content was published on Apr 5, 2001 The Swiss make a train journey 41 times a year on average, an achievement surpassed only by the Japanese who retain their world number one spot with an average of 70 journeys. The figures, released by the public transport information service on Thursday, show that the Swiss leave other European travellers way behind when it…

Profit slips at Publigroupe

This content was published on Apr 5, 2001 The Lausanne-based group was nevertheless upbeat about future prospects. It said the figures had exceeded the company’s forecasts issued in February, adding that the results at business units PubliPresse, Publicitas, Promotion Network and PubliDirect were better than expected. Publigroupe, which is Switzerland’s biggest seller of advertising, also announced that it would leave its dividend for…

SIG boosts drinks packaging business

This content was published on Apr 5, 2001 SIG is buying SASIB Wet for SFr90 million ($53.3 million) from Italy’s CIR group, which is a holding company of Italian tycoon Carlo de Benedetti. SASIB Wet, with an annual turnover of SFr742 million and a staff of 2,200, is among the leading suppliers of high-speed filling machines for drinks and is operated through the…

Internal: Archive

Popular Stories

Most Discussed

Internal: Archive

More

New worries for Switzerland’s troubled national exhibition

More

Prizes awarded for future scientific projects

More

Row grows over Swiss handling of foot-and-mouth disease

More

Cheaper alcohol undermines efforts to combat abuse

More

Novartis wins EU approval for diabetes treatment

More

Crossair forecasts return to profit

More

Say it with flowers from Africa

More

Swiss lead the world in train travel

More

Profit slips at Publigroupe

More

SIG boosts drinks packaging business

Popular Stories

Most Discussed